New obesity drug, Meridia

    Knoll is now shipping their new obesity drug, Meridia.

    Meridia (sibutramine) suppresses appetite by inhibiting the reuptake of norepinephrine...serotonin...and to a lesser extent, dopamine.

    This helps patients stick to a low calorie diet...leading to about a 5% to 10% weight loss.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote